Semaglutide is a GLP-1 receptor agonist peptide widely studied for its potential in regulating appetite, enhancing glycemic control, and promoting weight loss. Originally developed as a therapeutic candidate for type 2 diabetes and obesity, its mechanisms of action continue to be investigated across various metabolic and endocrine research pathways.
This compound is provided as a lyophilized powder in sterile, unlabeled glass vials to maintain optimal stability and purity in research settings. Each 10-vial research kit is manufactured under strict quality assurance protocols and undergoes independent third-party batch testing to verify identity and purity.
Each vial is intended for in vitro research use only. Not for human consumption. Not for therapeutic or diagnostic purposes.
